v3.26.3
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2024   250.0        
Beginning balance at Dec. 31, 2024 $ 20,180.0 $ 250.0 $ 16,069.0 $ 4,986.0 $ (1,151.0) $ 26.0
Net earnings 709.0     704.0   5.0
Net purchase of subsidiary shares from noncontrolling interests 3.0         3.0
Foreign currency translation 217.0       217.0  
Compensation expense related to stock option plan grants 18.0   18.0      
Common stock issued in:            
Purchase transactions (in shares)   0.1        
Purchase transaction 17.0 $ 0.1 17.0      
Stock option plans (in shares)   0.7        
Stock option plans 69.0 $ 0.7 68.0      
Employee stock purchase plan (in shares)   0.1        
Employee stock purchase plan 14.0 $ 0.1 14.0      
Stock issuance from public offering (in shares)   4.6        
Stock issuance from public offering 1,252.0 $ 4.6 1,248.0      
Shares issued to benefit plans (in shares)   0.3        
Shares issued to benefit plans 120.0 $ 0.3 119.0      
Deferred compensation and restricted stock (in shares)   0.3        
Deferred compensation and restricted stock (77.0) $ 0.3 (77.0)      
Cash dividends declared on common stock (167.0)     (167.0)    
Ending balance, (in shares) at Mar. 31, 2025   256.1        
Ending balance at Mar. 31, 2025 22,354.0 $ 256.1 17,475.0 5,523.0 (934.0) 34.0
Beginning balance (in shares) at Dec. 31, 2024   250.0        
Beginning balance at Dec. 31, 2024 20,180.0 $ 250.0 16,069.0 4,986.0 (1,151.0) 26.0
Net earnings 1,350.0          
Change in pension liability, net of taxes (7.0)          
Ending balance, (in shares) at Sep. 30, 2025   256.8        
Ending balance at Sep. 30, 2025 23,237.0 $ 256.8 17,706.0 5,824.0 (581.0) 31.0
Beginning balance (in shares) at Mar. 31, 2025   256.1        
Beginning balance at Mar. 31, 2025 22,354.0 $ 256.1 17,475.0 5,523.0 (934.0) 34.0
Net earnings 368.0     368.0   0.0
Net purchase of subsidiary shares from noncontrolling interests (1.0)         (1.0)
Change in pension liability, net of taxes (5.0)       (5.0)  
Foreign currency translation 428.0       428.0  
Change in fair value of derivative instruments, net of taxes 11.0       11.0  
Compensation expense related to stock option plan grants 11.0   11.0      
Common stock issued in:            
Stock option plans (in shares)   0.2        
Stock option plans 24.0 $ 0.2 24.0      
Employee stock purchase plan (in shares)   0.1        
Employee stock purchase plan 20.0 $ 0.1 20.0      
Deferred compensation and restricted stock (in shares)   0.0        
Deferred compensation and restricted stock 16.0 $ 0.0 16.0      
Cash dividends declared on common stock (171.0)     (171.0)    
Ending balance, (in shares) at Jun. 30, 2025   256.4        
Ending balance at Jun. 30, 2025 23,056.0 $ 256.4 17,546.0 5,720.0 (500.0) 33.0
Net earnings 273.0     272.0   1.0
Net purchase of subsidiary shares from noncontrolling interests (3.0)         (3.0)
Change in pension liability, net of taxes (2.0)       (2.0)  
Foreign currency translation (59.0)       (59.0)  
Change in fair value of derivative instruments, net of taxes (20.0)       (20.0)  
Compensation expense related to stock option plan grants 12.0   12.0      
Common stock issued in:            
Purchase transactions (in shares)   0.0        
Purchase transaction 6.0 $ 0.0 6.0      
Stock option plans (in shares)   0.1        
Stock option plans 11.0 $ 0.1 11.0      
Employee stock purchase plan (in shares)   0.1        
Employee stock purchase plan 31.0 $ 0.1 31.0      
Deferred compensation and restricted stock (in shares)   0.2        
Deferred compensation and restricted stock 100.0 $ 0.2 100.0      
Cash dividends declared on common stock (168.0)     (168.0)    
Ending balance, (in shares) at Sep. 30, 2025   256.8        
Ending balance at Sep. 30, 2025 $ 23,237.0 $ 256.8 17,706.0 5,824.0 (581.0) 31.0
Beginning balance (in shares) at Dec. 31, 2025 257.0 257.0        
Beginning balance at Dec. 31, 2025 $ 23,347.0 $ 257.0 17,783.0 5,806.0 (525.0) 26.0
Net earnings 823.0     822.0   1.0
Foreign currency translation (20.0)       (20.0)  
Change in fair value of derivative instruments, net of taxes (21.0)       (21.0)  
Compensation expense related to stock option plan grants 20.0   20.0      
Common stock issued in:            
Purchase transactions (in shares)   0.1        
Purchase transaction 17.0 $ 0.1 17.0      
Stock option plans (in shares)   0.4        
Stock option plans 36.0 $ 0.4 36.0      
Employee stock purchase plan (in shares)   0.1        
Employee stock purchase plan 15.0 $ 0.1 15.0      
Shares issued to benefit plans (in shares)   0.5        
Shares issued to benefit plans 132.0 $ 0.5 131.0      
Deferred compensation and restricted stock (in shares)   0.2        
Deferred compensation and restricted stock (55.0) $ 0.2 (55.0)      
Common stock repurchases (in shares)   (1.4)        
Common stock repurchases (310.0) $ (1.4) (309.0)      
Cash dividends declared on common stock (182.0)     (182.0)    
Ending balance, (in shares) at Mar. 31, 2026   256.9        
Ending balance at Mar. 31, 2026 $ 23,802.0 $ 256.9 17,638.0 6,446.0 (566.0) 27.0
Beginning balance (in shares) at Dec. 31, 2025 257.0 257.0        
Beginning balance at Dec. 31, 2025 $ 23,347.0 $ 257.0 17,783.0 5,806.0 (525.0) 26.0
Net earnings 1,553.0          
Change in pension liability, net of taxes $ 0.0          
Common stock issued in:            
Stock option plans (in shares) 0.9          
Ending balance, (in shares) at Sep. 30, 2026 256.4 256.4        
Ending balance at Sep. 30, 2026 $ 24,071.0 $ 256.4 17,584.0 6,809.0 (611.0) 33.0
Beginning balance (in shares) at Mar. 31, 2026   256.9        
Beginning balance at Mar. 31, 2026 23,802.0 $ 256.9 17,638.0 6,446.0 (566.0) 27.0
Net earnings 324.0     324.0   0.0
Net purchase of subsidiary shares from noncontrolling interests 3.0         3.0
Foreign currency translation (134.0)       (134.0)  
Change in fair value of derivative instruments, net of taxes 6.0       6.0  
Compensation expense related to stock option plan grants 15.0   15.0      
Common stock issued in:            
Stock option plans (in shares)   0.2        
Stock option plans 18.0 $ 0.2 18.0      
Employee stock purchase plan (in shares)   0.1        
Employee stock purchase plan 22.0 $ 0.1 22.0      
Deferred compensation and restricted stock (in shares)   0.0        
Deferred compensation and restricted stock 43.0 $ 0.0 43.0      
Common stock repurchases (in shares)   (0.9)        
Common stock repurchases (170.0) $ (0.9) (169.0)      
Cash dividends declared on common stock (182.0)     (182.0)    
Ending balance, (in shares) at Jun. 30, 2026   256.3        
Ending balance at Jun. 30, 2026 23,747.0 $ 256.3 17,567.0 6,588.0 (694.0) 30.0
Net earnings 406.0     403.0   3.0
Net purchase of subsidiary shares from noncontrolling interests 0.0         0.0
Change in pension liability, net of taxes 0.0          
Foreign currency translation 88.0       88.0  
Change in fair value of derivative instruments, net of taxes (5.0)       (5.0)  
Compensation expense related to stock option plan grants 14.0   14.0      
Common stock issued in:            
Purchase transactions (in shares)   0.1        
Purchase transaction 13.0 $ 0.1 13.0      
Stock option plans (in shares)   0.2        
Stock option plans 29.0 $ 0.2 29.0      
Employee stock purchase plan (in shares)   0.1        
Employee stock purchase plan 34.0 $ 0.1 34.0      
Deferred compensation and restricted stock (in shares)   0.1        
Deferred compensation and restricted stock 26.0 $ 0.1 26.0      
Common stock repurchases (in shares)   (0.4)        
Common stock repurchases (99.0) $ (0.4) (99.0)      
Cash dividends declared on common stock $ (182.0)     (182.0)    
Ending balance, (in shares) at Sep. 30, 2026 256.4 256.4        
Ending balance at Sep. 30, 2026 $ 24,071.0 $ 256.4 $ 17,584.0 $ 6,809.0 $ (611.0) $ 33.0